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Drug development often relies on high-throughput cell-based screening of large compound
libraries. However, the lack of miniaturized and parallelized methodologies in chemistry as
well as strict separation and incompatibility of the synthesis of bioactive compounds from
their biological screenings makes this process expensive and inefﬁcient. Here, we demon-
strate an on-chip platform that combines solution-based synthesis of compound libraries with
high-throughput biological screenings (chemBIOS). The chemBIOS platform is compatible
with both organic solvents required for the synthesis and aqueous solutions necessary for
biological screenings. We use the chemBIOS platform to perform 75 parallel, three-
component reactions to synthesize a library of lipidoids, followed by characterization via
MALDI-MS, on-chip formation of lipoplexes, and on-chip cell screening. The entire process
from the library synthesis to cell screening takes only 3 days and about 1 mL of total solutions,
demonstrating the potential of the chemBIOS technology to increase efﬁciency and accel-
erate screenings and drug development.
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The pharmaceutical industry struggles to meet the ever-increasing demand for new drugs. A decrease in thedevelopment of new drugs has been observed for years1.
From 1991 to 2000, the total number of new drugs discovered in
the 21 leading countries was 367, dropping to 251 for the period
2001–20102. Fewer and fewer new drugs are being tested in
clinical trials, and R&D takes longer to develop potential new
drug candidates1.
The process of developing drugs as well as various other fun-
damental and applied biological experiments begins from the
organic synthesis of compound libraries, followed by their high-
throughput screening in biological assays to identify few active
molecules (hits) (Fig. 1). Most of the compounds available in
primary and secondary libraries are synthesized individually via
standard organic synthesis usually involving large quantities of
reagents and organic solvents. This makes library synthesis an
extremely lengthy and costly process taking many years and
consuming valuable resources. Despite these well-established
procedures and methods, it often takes over 20 years and $2–4
billion between a single drug’s ﬁrst synthesis3, biological
screening4,5 and ultimate approval6.
There are many reasons for such slow progress in drug devel-
opment, ranging from typical problems such as poor lead opti-
mization, limited speciﬁcity, and potential toxicity. Furthermore,
due to high costs and low availability, primary screenings are
usually only done once (without repeating or varying concentra-
tions), and only in big pharmaceutical companies or screening
centers. Organic synthesis in ﬂasks with large volumes, organic
solvents, and harsh conditions renders it incompatible with any
biological assay, which are usually performed in polystyrene
microtiter plates, requiring small volumes, mild aqueous condi-
tions, and compatibility with the corresponding infrastructure
(microscopy, pipetting, parallelization, and miniaturization).
Microarrays have been used to try to overcome these problems.
Solid-phase synthesis (SPS) in the microarray format is one
example showing the potential of miniaturization and combina-
tion with the biological part. Microarrays of DNA, peptide
microarrays, small molecule microarrays or oligosaccharide
microarrays produced by SPS have been demonstrated7–13.
Although these SPS methods have accelerated the development
and investigation of large and diverse compound libraries because
of their inherent miniaturization and parallelization, solution-
based synthesis offers a much broader scope of chemical reac-
tions. Moreover, most of the existing SPS methods are incom-
patible with more physiologically relevant cellular assays (2D or
3D cell culture) where freely diffusing compounds and therefore
compartmentalization of individual cell experiments are required.
Surprisingly, despite the well-established procedure for high-
throughput screenings (HTS) and drug discovery, and apart from
a pharmaceutical industry that reportedly screens millions of
compounds every year, there are very few academic publications
on HTS entailing more than 10,000 compounds. For example,
Torrance et al. screened 29,440 different compounds to identify
active agents that inhibit tumor xenografts14. The reasons for the
above are clearly understood if we approximate the costs of such
HTSs starting from the synthesis part and up to biological
screenings. For example, if we had to synthesize 100,000 different
compounds for a subsequent biological screening, even if each
reaction required only 10 mL of solvents and biological assay
(standard 384-well MTPs) would need 60 µL (20 µL in triplicates),
the total volume of organic solvents would amount to 1000 L and
aqueous solutions at least to 6 L for each bioassay. The most
important limitation, however, is the time needed for the
synthesis part. For example, if one chemist had to do this library
synthesis at a speed of ﬁve compounds per day, it would take
55 years. This illustrates the underlying problem for the entire
ﬁeld of drug discovery and explains the slow development and
exorbitant costs (on average $2–4 billion per drug15–18) in this
ﬁeld essential to everyone.
Although it remains very challenging to unify chemical
synthesis with the biological screening part to enable faster
transfer and utilization of the synthesized compounds in biolo-
gical screenings, we believe this is the most efﬁcient pathway to
solve the aforementioned problems.
Here we develop a microarray platform compatible with the
solution-based organic synthesis of combinatorial libraries of
small molecules that are easily screenable in various biological
and cell-based assays using the same platform (chemBIOS;
Fig. 1). As a proof-of-concept, we use the chemBIOS platform to
synthesize a library of lipid-like molecules (lipidoids), followed by
the on-chip preparation of lipoplexes and the on-chip cell
screening to identify transfection reagents.
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Fig. 1 Schematic describing the process of drug discovery. Strict separation between chemistry (synthesis) and biology (assays) makes the process of drug
discovery inefﬁcient. ChemBIOS uniﬁes miniaturized solution-based chemical synthesis performed in a microarray format, characterization and biological
screening, and thus, all steps in early-stage drug discovery take a few days rather than years. Scale bar: 200 μm
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Results
Manufacturing and characterization of the platform. Our entire
validation of the chemBIOS process was conducted in four steps:
(i) manufacturing and characterizing the platform, (ii) on-chip
synthesis and characterization of a lipidoid library, (iii) on-chip
formation of liposomes and lipoplexes, and (iv) on-chip cellular
screening of produced lipoplexes.
A compound library was synthesized using omniphilic-
omniphobic microarrays prepared on glass slides compatible
with low surface tension organic liquids, thus called Low
Surface Tension Liquids (LSTL) slides19. To manufacture LSTL
slides, we ﬁrst modiﬁed the surface of the glass slide with chloro
(dimethyl)vinylsilane to produce a monolayer of reactive
vinyl groups on the surface. Afterwards, the photochemical
patterning of the surface via the thiol-ene photoclick reaction
(Fig. 2a) led to the formation of omniphilic spots functionalized
with cysteamine hydrochloride (θadv(DMSO)= 32.9 ± 2.4°,
θrec(DMSO)= 17.9 ± 2.2°), spatially separated by omniphobic
borders functionalized with 1H, 1H, 2H, 2H-perﬂuorodeca-
nethiol (PFDT) (θadv(DMSO)= 87.0 ± 3.5°, θrec(DMSO)=
72.2 ± 1.7°) (Fig. 2c and Supplementary Fig. 1). In all, ± values
of all contact angle measurements are standard deviations based
on triplicate experiments. Due to the omniphilic-omniphobic
properties of these patterns and excellent dewetting characteristics
of the ﬂuorinated regions, low surface tension liquids including
various common organic solvents (such as n-hexane, ethanol, 1-
decanol, DMF, and DMSO (Supplementary Fig. 2)) could form
arrays of microdroplets via the effect of discontinuous dewetting
(Fig. 2e)19. The shape and volume of these droplets could be
deﬁned by varying the geometry of the patterns. Depending on
the patterns and solvent, we could create droplets from few
picoliters up to microliters20. However, LSTL slides cannot be
used to form droplet arrays employing aqueous solutions
with much higher surface tension, due to the relatively high
receding contact angle of the water on the hydrophilic regions
(θrec(H2O)= 33.7 ± 0.8°; Supplementary Fig. 1).
Therefore, in the next step we produced High Surface
Tension Liquids (HSTL) slides—glass slides coated with a
porous polymer layer patterned with hydrophilic spots
separated by hydrophobic barriers, leading to the effect of
discontinuous dewetting of aqueous solutions21,22. The pre-
paration of HSTL slides occurs via the photochemical patterning
of a thin, porous layer of poly(2-hydroxyethyl methacrylate-co-
ethylene dimethacrylate) (HEMA-co-EDMA polymer). Highly
hydrophilic spots functionalized with 2-mercaptoethanol
(θadv(H2O)= 19.2 ± 1.6°, θrec(H2O)= 6.3 ± 1.1°) and spatially
separated by highly hydrophobic borders functionalized with
PFDT (θadv(H2O)= 159.3 ± 6.8°, θrec(H2O)= 139.6 ± 2.2°) were
generated via the photochemical thiol-yne photoclick reaction
(Fig. 2b, d and Supplementary Fig. 1). The combination of
highly hydrophilic spots possessing very strong afﬁnity to
aqueous solutions and hydrophobic, extremely water-repellent
regions enabled the formation of arrays of droplets of high
surface tension aqueous solutions such as liposomes or cell
suspension using discontinuous dewetting (Supplementary Fig. 3
and Supplementary Movie 1).
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Fig. 2 Manufacture and characterization of patterned slides used for the chemBIOS platform. The chemBIOS platform consists of two types of patterned
glass slides. a Slides compatible with Low Surface Tension Liquids (LSTL slides) are produced by silanizing the glass surface with chloro(dimethyl)
vinylsilane and patterning via the photochemical thiol-ene click reaction. Omniphobic borders are generated by a reaction with perﬂuorodecanethiol
(PFDT), followed by the formation of omniphilic spots by cysteamine hydrochloride. Spot diameter 2.83mm; hydrophobic borders width 1.67 mm. b Slides
for High Surface Tension Liquids (HSTL slides) are manufactured via a polymerization reaction to apply a porous polymer layer of poly(2-hydroxyethyl
methacrylate-co-ethylene dimethacrylate). Functionalization with 4-pentynoic acid enables further surface patterning by thiol-yne photoclick chemistry.
Hydrophobic borders are generated by PFDT, followed by the formation of hydrophilic spots using 2-mercaptoethanol. Spot diameter 2.83 mm;
hydrophobic borders width 1.67 mm. c Photographs of droplets of DMSO on the omniphobic surface and omniphilic surfaces used for the LSTL patterns
with corresponding static contact angle. Droplet volume: 10 µL. d Photographs of droplets of water on hydrophobic and hydrophilic surfaces used for the
HSTL slides with corresponding static contact angle. Droplet volume: 10 µL. e Schematic showing the effect of discontinuous dewetting on patterned LSTL
slides, which enables manual generation of organic droplet arrays
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On-chip synthesis and characterization of a lipidoid library.
We then used the LSTL slides to develop and optimize the par-
allel, combinatorial synthesis of cationic lipid-like molecules
(lipidoids) to be used in the following cell screening experiment.
For this purpose, we chose a one-pot three-component reaction
based on thiolactone opening by an amine, followed by a disulﬁde
exchange reaction (Fig. 3b)23. We used two methods to apply
solutions in droplet-array format to the slides: a printing method,
where we applied droplets to each spot via a non-contact liquid
dispenser system, and the rolling droplet method, where we
applied solutions via discontinuous dewetting. The rolling droplet
method was only used to synthesize the lipidoids characterized by
MALDI-TOF mass spectrometric analysis and is described below.
Solutions of various amines (A1–A5) in DMSO were applied in a
column-by-column manner on an LSTL slide A to form an array
of different amines in each row (Fig. 3a). The thiolactone and
pyridyl disulﬁde reactants were premixed together in DMSO in
different combinations and applied on a LSTL slide B in row-by-
row manner perpendicular to the columns in slide A (Fig. 3a). By
sandwiching both slides using an aligner device (Supplementary
Fig 4), the droplets on slides A and B were merged in array
format, initiating the chemical reaction simultaneously in each
droplet on the array (Fig. 3a). Using this method, we were able to
synthesize a library of 25 different compounds, each in triplicate
on the same slide in a single step (Supplementary Table 1). The
reaction was carried out for 2 h at room temperature.
We used the released 2-thiopyridone to monitor the reaction
kinetics and estimate the yield via UV-Vis spectroscopy. The
extinction coefﬁcient of 2-thiopyridon in DMSO/acetonitrile (1:10)
was independently estimated to be 2040M−1 cm−1 at 370 nm
(Supplementary Fig. 5a). To monitor the progress of the reaction,
we took one droplet from the array, diluted it in 90 µL acetonitrile,
and analyzed it by UV-Vis. Based on those UV-Vis results, the
reaction was complete after two hours (Supplementary Fig. 5b).
By quantifying the absolute concentration of 2-thiopyridone, we
indirectly calculated the average yield of 89 ± 15% by Beer-Lambert
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Fig. 3 On-chip synthesis and characterization of a lipidoid library. a Schematic description of combinatorial synthesis of lipidoids using the chemBIOS
platform. In the ﬁrst step, various amines dissolved in DMSO are applied column-by-column onto a low surface tension liquids (LSTL) slide A. Then,
mixtures of thiolactone and pyridyl disulﬁde derivates dissolved in DMSO are applied on a LSTL slide B in rows oriented orthogonally to the columns on
slide A. The application is done by rolling a droplet of solution to form rows of separate droplets. In the next step, slide A and slide B are sandwiched (SW)
with each other to bring individual droplets into contact to merge the droplets, thereby initiating the reaction. The reaction was completed after 2 h at room
temperature. 25 different lipidoids per slide were synthesized in triplicates on a single slide. b Scheme of the reaction and a list of all different precursors for
the reaction. c To characterize produced compounds, slide A was sandwiched onto a MALDI plate, followed by the addition of matrix and drying the plate.
MALDI-TOF mass spectrometry measurement (examples of spectra shown in the insets, positive mode) enables rapid and convenient characterization of
the entire library of synthesized compounds. (i) sandwiching, followed by adding 10mgmL−1 α-cyano-4-hydroxycinnamic acid solution of 1:1 acetonitrile:
water containing 0.1% v/v triﬂuoroacetic acid. Source data are provided as a Source Data ﬁle
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law (Supplementary Fig. 5c and Supplementary Table 1). In all,
± values of all reaction yields are standard deviations based
on triplicate experiments. The products of the reaction were
analyzed via MALDI-TOF mass spectrometry (MS). The
open system and ﬂat substrate of chemBIOS enabled us to transfer
and copy the entire compound library in a single step by stamping
it onto a MALDI plate (Fig. 3c and Supplementary Fig. 6).
Moreover, we characterized the raw product by 1H-NMR
(Supplementary Fig. 7) and on-chip ATR-IR spectroscopy
(Supplementary Fig. 8).
The open format of the chemBIOS system is compatible with
further on-chip steps such as investigating, treating or
converting the chemical compound library, to achieve
high-throughput parallel on-chip puriﬁcation. In a proof-
of-principle experiment, we showed how crude products could
be puriﬁed by on-chip two-phase liquid extraction (Fig. 4a, b).
Therefore, we dissolved Nile red and methylene blue in
1-octanol which resulted in a dark blue solution. Next, we
applied this solution on several spots on an LSTL slide D and
sandwiched that slide with an HSTL slide E containing water
droplets, resulting in the formation of an octanol-water
interface for each droplet (Fig. 4a). Methylene blue is highly
water-soluble, and was therefore extracted from the organic
phase into the aqueous phase, while water-insoluble Nile red
remained in the organic phase. The organic phase turned red
after 10 min, while the aqueous phase turned blue, indicating
successful separation. We analyzed the mixture before puriﬁca-
tion, as well as the organic and aqueous phases after
puriﬁcation by UV-Vis spectroscopy (Fig. 4b) and liquid
chromatography mass spectrometry (LC-MS) (Supplementary
Fig. 9 and 10). Both analytical methods yielded similar results.
Using UV-Vis spectroscopy, the concentration of methylene
blue measured 11.9 ± 0.5 mM in the original organic phase
mixture, and 3.3 ± 0.6 mM and 4.1 ± 0.4 mM in the organic and
aqueous phase, respectively, after extraction. The concentration
of Nile red was measured 6.0 mM in the original mixture, and
4.3 ± 0.3 mM and 0.3 ± 0.04 mM in the organic and aqueous
phase after extraction. This corresponds to the puriﬁcation of
the methylene blue from 66% in the mixture to 91% in
the aqueous phase and that of Nile red from 34% in the mixture
to 57% in the organic phase via just one puriﬁcation step. In all,
±values of all concentration measurements are standard
deviations based on triplicate experiments.
On-chip formation of liposomes and lipoplexes. In the next
step, we transferred the lipidoid library from the LSTL slide A to
an HSTL slide C (Fig. 5a). This step was performed to transfer
lipidoids into aqueous cell-compatible droplets simultaneously,
forming either liposomes or lipoplexes required for cell trans-
fection experiments. To make lipoplexes or liposomes, the LSTL
slide A containing dried lipidoids was sandwiched with HSTL
slide C containing an array of droplets of an aqueous sodium
acetate buffer (50 mM, pH 5) with or without plasmid pCS2-GFP
(75 ng µL−1), respectively. The buffer also contained 0.04% w/v
gelatin, 3.4% w/v sucrose, 0.002% w/v human ﬁbronectin
required for the subsequent reverse cell transfection experi-
ment24. The sandwiched slides were incubated at 50 °C for 1.5 h
to support the formation of liposomes/lipoplexes. As a result, the
synthesis products were transferred to the HSTL slide C. Having
been transferred into an aqueous environment, the amphiphilic
lipidoids spontaneously formed liposomes, subsequently com-
plexing plasmid DNA to form lipoplexes (Fig. 5a). We char-
acterized both liposome and lipoplex solutions by pipetting them
directly from the HSTL slide C into a cuvette to analyze via
dynamic light scattering (DLS) and zeta potential analysis. The
lipoplex solutions revealed signiﬁcantly larger particles than the
corresponding liposome solutions (Fig. 5b). Furthermore, lipo-
plex solutions demonstrated a lower zeta potential than the cor-
responding liposomes, indicating the formation of complexes
between the positively charged lipidoids and negatively charged
DNA (Fig. 5b).
On-chip cell-based screening of produced lipoplexes. Next, we
investigated the lipoplex library in an on-chip cell-based screen-
ing using reverse transfection of HEK293T cells (Fig. 6a).
ScreenFect A was used as a positive control, while dilution
buffer without pDNA and untreated cells served as negative
controls. The transfection experiment was performed by printing
5 µL of a suspension of 6 × 105 HEK293T cells mL−1 into each
spot on the dried lipoplex array slide using a non-contact liquid
LSTL slide D
1-Octanol
N
NOO
N
N
+
N S
HSTL slide E
H2O
LSTL slide D
HSTL slide E
1-Octanol
H2O
SW
rt, 10 min
LSTL slide D
HSTL slide E
H2O
1-Octanol
Interface
1,0
Mixture
Organic phase
Aqueous phase
λmax (nile red)
= 541 nm
λmax (methylene blue)
= 654 nm
0,8
0,6
0,4
0,2
0,0
300 400 500 600 700
Wavelength [nm]
A
bs
or
ba
nc
e
Nile red
Methylene blue
a b
↔
O O
O O
N
N
N
N
N
N
S
S
N
N
N
N
+
+
Fig. 4 On-chip parallel liquid-liquid extraction. a Schematic description of the on-chip two-phase liquid extraction process. A mixture of oleophilic Nile red
and hydrophilic methylene blue in 1-octanol on an LSTL slide D was separated by sandwiching the slide with an HSTL slide E carrying water droplets for
10min. An interface between the two non-miscible solvents was formed, and the water-soluble methylene blue was extracted into the aqueous phase.
b Validation of the on-chip extraction via UV-Vis spectroscopy. The UV-Vis spectrum of the mixture reveals two local absorbance maxima: one at 541 nm
corresponding to Nile red, and another at 654 nm corresponding to methylene blue. After the extraction, the intensity of the absorbance maximum of
methylene blue in the organic phase decreased while the intensity of Nile red remained constant. In the aqueous phase, no Nile red could be detected.
Source data are provided as a Source Data ﬁle
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dispenser. After 48 h of cultivating and staining the cells with
Hoechst and propidium iodide (PI), we determined the transfec-
tion efﬁciency of each sample of the array by ﬂuorescence
microscopy (Fig. 6b, c and Supplementary Table 2). We observed
that sample A3_T14_PY14 was the best performing transfection
agent in our screening with 52 ± 4% average transfection
efﬁciency (Fig. 6b). Viability of cells in the negative control
experiment (spots without lipidoids and only treated with buffer
solution) was 97 ± 1%, while cells transfected with the most
efﬁcient lipoplexes demonstrated ~34% viability as measured by
PI/Höchst staining (Supplementary Fig. 8).
Discussion
The process of developing biologically active compounds and
potential drug candidates is difﬁcult due to several factors. The
transfer of commercially available drug libraries into a suitable
screening format poses huge handling and logistics challenges.
The parallel addition of reagents and solutions, and the transfer to
another platform requires many multi-pipetting steps and thus
large amounts of consumables as well as the loss of material due
to large dead volumes. The handling of very large drug libraries is
often impossible for a single individual to accomplish within a
reasonable time. Additional labor costs make the development of
bioactive compounds prohibitively expensive. Furthermore,
commercially available drug libraries are extremely costly, and the
number of available compounds remains limited. Synthesizing
new compounds is very time- and resource-consuming, since
traditional solution-based organic synthesis is not designed for
miniaturized and parallelized applications. In addition, the tem-
poral and spatial separation of synthesis, characterization, and
biological screening signiﬁcantly slows down entire biological
discovery and drug development pipelines. There is currently no
system that could efﬁciently hyphenate these parts.
To solve these challenges, we developed a chemBIOS platform
that uniﬁes the miniaturized combinatorial solution-based
organic synthesis in the microarray format and biological high-
throughput screenings. The platform uses LSTL slides with
omniphobic-omniphilic patterns to form arrays of organic sol-
vents, where each droplet functions as a separate microreactor for
solution-based organic synthesis. Furthermore, sandwiching the
array with another droplet array enables the rapid and parallel
addition, transfer, and copying of the whole library. For example,
we carried out a three-component lipidoid combinatorial synth-
esis to create a library of 25 small molecules in triplicates
(Fig. 3b). By sandwiching two droplet arrays, we simultaneously
mixed all educts in 75 droplets and thus initiated the synthesis of
an entire library in a single step (Fig. 3a). Although this platform
can be readily utilized for many types of solution-based reactions
using various organic or aqueous solvents, there are still some
challenges in adapting other chemical techniques. Reactions at
elevated temperatures and highly exothermic reactions as well as
adding solid reagents or purging gaseous educts might be difﬁcult
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Fig. 5 On-chip parallel formation of a library of liposomes or lipoplexes. a Schematic description of lipoplex formation. An array (HSTL slide C) of aqueous
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to realize using the chemBIOS platform in its current state.
Chemical reactions requiring a protective atmosphere or con-
trolled pressure are feasible, but would require a closed chamber
with controlled pressure and atmosphere. On-chip parallel high-
throughput puriﬁcation is another key challenge that we will be
focusing on in future studies. The advantages of the chemBIOS
platform are that its conﬁguration is open and ﬂat, making all
microcompartments accessible and potentially compatible with
parallel high-throughput puriﬁcation methods, e.g. on-chip
extraction (Fig. 4a, b).
Due to the low sensitivity, most organic synthesis char-
acterization methods are often incompatible with the micro-,
nano- or even picomolar scale reactions required for high-
throughput miniaturized synthetic applications. MALDI-TOF
mass spectrometry is the method of choice for characterizing
small quantities of compounds in a parallel way. The open
system of the chemBIOS platform enabled us to copy the entire
droplet-based library in a single step by stamping it onto a
MALDI plate, followed by mass spectrometric analysis (Fig. 3c).
Besides MALDI-TOF MS, compounds synthesized on the
chemBIOS platform can be characterized via on-chip IR spec-
troscopy (Supplementary Fig. 8). This demonstrates another
important advantage of the chemBIOS platform’s ﬂat, open
droplet microarray system, which makes it compatible with
other analytical methods such as Raman spectroscopy or
surface sensitive methods including DESI-MS or time-of-ﬂight
secondary ion mass-spectrometry.
We also demonstrated the feasibility of transferring the che-
mical compounds from the LSTL to a HSTL slide in a parallel
manner that enables rapid and convenient hyphenation between
the two realms—chemical and biological. We used HSTL slides to
create highly hydrophilic-hydrophobic microarrays that could be
used to form the arrays of aqueous droplets needed for bio-
chemical and cellular screenings. We demonstrate the single-step
transfer of the entire lipidoid library from the platform for
organic solvents (LSTL slide) to the platform for aqueous solvents
(HSTL slide) by simply sandwiching both types of slides. The
single-step formation of liposomes and lipoplexes during this
transfer step was proved by dynamic light scattering and zeta
potential analysis—observing higher zeta potentials for liposomes
than for lipoplexes (Fig. 5b). The lipoplexes we produced were
successfully screened with cells by printing cellular suspension
into the individual spots containing lipoplexes to perform a
reversed cell transfection experiment (Fig. 6). The screening of
lipidoids to determine their cell transfection efﬁciency using
plasmid DNAs is an example of a biological assay that is com-
binable with synthesized libraries. Other possible biological
experiments include, inter alia, CRISPR/Cas9-based gene editing,
screening of membrane proteins, gene-knockdown, and
the screening of cell spheroids or organoids. Overall, this
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Fig. 6 On-chip reversed cell transfection screening of the produced lipoplex library. a Schematic showing the process of on-chip cell transfection screening.
Five microliter of HEK293T cell suspensions were printed into each hydrophilic spot on the HSTL slide C covered by the dried lipoplex cell transfection
mixture. After incubating the array for 48 h at 36 °C and 5% CO2, 1 µL of staining solution was printed into each droplet, followed by 15min incubation and
ﬂuorescence microscopy analysis. b Bar chart visualizing mean values of transfection efﬁciencies (number of GFP-transfected cells per total cell number)
calculated based on three independent experiments (overlaid dot plots) covering the entire pipeline including on-chip library synthesis, formation of lipoplexes
and cell transfection. A3_T14_PY14 lipidoid proved to be most efﬁcient in our study, resulting in 52 ± 4% transfection efﬁciency. Error bars are standard
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demonstrates the possibility to hyphenate combinatorial organic
chemistry with biological screenings using the chemBIOS plat-
form. Unifying chemistry and biology both temporally and spa-
tially on the same platform accelerates the entire process of
developing bioactive compounds important for various applica-
tions. Using the chemBIOS platform, in situ synthesized small
molecule libraries can be screened immediately for their biolo-
gical activity, thereby saving time, effort, chemicals, cells, and
other consumables. The entire procedure of synthesizing (3 µL
organic solvent), transferring/processing (4.5 µL aqueous solvent)
and screening (5 µL cell suspension +1 µL staining solution) of a
single lipidoid took only 3 days and about 13.5 µL of solutions,
whereas the traditional bulk procedure requires at least several
milliliters per compound. This allowed us to repeat the whole
process from the synthesis to the biological screening multiple
times; our ﬁnal analysis of transfection efﬁciency by ﬂuorescence
microscopy yielded reproducible transfection results for all the
library compounds (Fig. 6b). The platform is compatible with
further miniaturization, despite possible future challenges asso-
ciated with further reductions in droplet size, such as faster sol-
vent evaporation, difﬁcult alignment during the sandwiching
process, compatibility with and sensitivity of analytical methods.
In summary, by unifying on-chip in situ miniaturized and
parallelized solutions-based combinatorial synthesis of bioactive
compounds, the feasibility of rapid and parallel characterization
by copying the library microarray onto a separate slide for ana-
lysis (e.g. MALDI-MS), and on-chip biological and cellular
screenings, the chemBIOS platform hyphenates all aspects of
early-stage drug discovery, which will be useful for various other
biological or biotechnological screening applications.
Methods
Preparation of high surface tension liquids slides. Activation of the surface of
standard microscope glass slides (25 × 75 × 1mm, width × length × thickness,
Schröder Spezialglas) was done by immersing them in 1M NaOH (Carl Roth) for
1 h, followed by neutralization in 1M HCl (Merck) for 30 min. Activated glass
slides were modiﬁed with 20% v/v solution of 3-(trimethoxysilyl)propyl metha-
crylate (Sigma-Aldrich) in ethanol (Merck) for 40 min at room temperature. Next,
35 µL of polymerization mixture (24 wt% 2-hydroxyethyl methacrylate (Sigma),
16 wt% ethylene dimethacrylate (Sigma-Aldrich), 12 wt% 1-decanol (Merck),
48 wt% cyclohexanol (Sigma), and 0.4 wt% 2,2-dimethoxy-2-phenylacetophenone
(Sigma-Aldrich)) was applied onto a ﬂuorinated glass slide and covered with a
modiﬁed glass slide to introduce a polymer layer. Polymerization was carried out
by UV irradiation (OAI model 30) with 4 mW cm−2 intensity and 260 nm wave-
length for 15 min. Fluorination of glass slides was done by incubating slides in a
closed vacuumed desiccator in the presence of an open vial containing 30 µL of
trichloro(1H, 1H, 2H, 2H-perﬂuorooctyl)silane (Sigma) for 16 h under 50 mbar
vacuum. Modiﬁcation of the polymer layer was done by incubating the slides in
modiﬁcation mixture (56 mg of 4-(dimethylamino)pyridine (Novabiochem),
111.6 mg 4-pentynoic acid (Sigma-Aldrich) and 180 µLN,N’-diisopropylcarbodii-
mine (Alfa Aesar) in 45 mL dichloromethane (Merck)) for 4 h while stirring at
room temperature. The surface was patterned by ﬁrst generating the hydrophobic
borders. Three hundred microliter of a 8% v/v solution of 1H, 1H, 2H, 2H-per-
ﬂuorodecanethiol (Sigma-Aldrich) in acetone (Merck) was applied onto the
polymer surface and the thiol-yne click reaction carried out by irradiating the slide
through a photomask (Rose Fotomasken) with 260 nm UV light (OAI model 30) at
4 mW cm−2 intensity for 1 min. Round hydrophilic spots with a diameter of
2.83 mm were formed by applying 200 µL of a 10% v/v β-mercaptoethanol (Alfa
Aesar) solution in 1:1 water:ethanol onto the patterned surface and irradiating the
slide with 260 nm, UV light (OAI model 30) at 4 mW cm−2 intensity for 1 min.
Preparation of low surface tension liquids slides. An activated glass slide was
modiﬁed by inserting into modiﬁcation mixture (0.8 mL triethylamine (VWR),
50 mg of 4-dimethylaminopyridine (Merck), 0.2 mL chloro(dimethyl)vinyl silane
(Sigma-Aldrich) in 49 mL dichloromethane) for 2 min under stirring at room
temperature. The slide surface was patterned by ﬁrst applying 300 µL of a 20% v/v
solution of 1H, 1H, 2H, 2H-perﬂuorodecanethiol (Sigma-Aldrich) in acetone onto
the modiﬁed surface and carried out a thiol-ene photoclick reaction by irradiating
the slide through a photomask (Rose Fotomasken) with 260 nm UV light (OAI
model 30) at 4 mW cm−2 intensity for 1 min to create omniphobic borders. Round
omniphilic spots with a diameter of 2.83 mm were formed by applying 200 µL of a
10 wt% cysteamine hydrochloride (Alfa Aesar) solution in 1:2 water:ethanol onto
the patterned surface and irradiating the slide with 260 nm, UV light (OAI model
30) at 4 mW cm−2 intensity for 1 min.
Surface characterization. The surface of each slide was characterized by contact
angle measurements using Drop Shape Analyzer DSA25 (Krüss). For HSTL slides
we measured the advancing, static and receding contact angle by applying 40 µL
(speed 0.3 µL s−1) deionized water on hydrophobic and hydrophilic surfaces. For
LSTL slides we measured the advancing, static and receding contact angle by
applying 40 µL (speed 0.3 µL s−1) DMSO (VWR) and deionized water on omni-
phobic and omniphilic surfaces.
Synthesis and characterization of a lipidoid library. On-chip synthetic proce-
dure was performed in a standard chemistry fume hood.Stock solutions of dif-
ferent amines (Sigma-Aldrich) 1:24 v/v in DMSO and stock solutions of mixtures
of different thiolactones (1.67 mg mL−1) and pyridyl disulﬁdes (1.75 mg mL−1) in
DMSO were prepared. The on-chip synthesis of a lipidoid library via the rolling
droplet method was performed by applying 3 µL of different amine solutions to
each spot column-by-column in an array on a LSTL slide A and 3 µL of different
mixtures of thiolactones and pyridyl disulﬁdes to each spot row-by-row in an
array on a LSTL slide B perpendicular to the columns on slide A by discontinuous
dewetting. The reaction was carried out by sandwiching both slides using an
alignment frame for 2 h at room temperature. For characterization, the synthe-
sized library was stamped onto a MALDI plate (Applied Biosystems). Solvent was
evaporated in a desiccator under vacuum. Mass spectrum of each raw product
was measured by 4800 MALDI TOF/TOF Analyzer (Applied Biosystems)
using a 10 mg mL−1 α-cyano-4-hydroxycinnamic acid (Alfa Aesar) solution of
1:1 acetonitrile:water containing 0.1% v/v triﬂuoroacetic acid (Merck). Further
characterization by UV-Vis was done by Lambda 35 UV-Vis spectrometer
(PerkinElmer). On-chip ATR-IR spectroscopy was done by Tensor 27 (Bruker).
For characterization by 1H-NMR spectroscopy (Bruker 400 MHz), we synthe-
sized one lipidoid on a whole array as described above, then evaporated the
solvent and washed down the raw product with dichloromethane (Merck)
from LSTL slides into a round bottle ﬂask. We evaporated the solvent under
high vacuum and dissolved the raw product in deuterated chloroform (VWR)
for analysis.
The on-chip synthesis of a lipidoid library via the printing method was
performed by printing 1.5 µL of different amine solutions to each spot column-by-
column in an array on a LSTL slide A using a non-contact liquid dispenser (I-DOT;
Dispendix). Next, 1.5 µL of different mixtures of thiolactones and pyridyl disulﬁdes
were printed to each spot row-by-row on the same array perpendicular to the
columns of previously printed amine solutions using a non-contact liquid
dispenser (I-DOT; Dispendix). The reaction was carried for 2 h at room
temperature before the solvent was evaporated in a desiccator under vacuum.
This synthesizing method was used for all experiments except the
characterization experiments by MALDI TOF MS.
On-chip puriﬁcation. On-chip puriﬁcation was performed in a standard chemistry
fume hood: Three microliter per spot of a mixture of Nile red (2.1 mg mL−1;
Sigma-Aldrich) and methylene blue hydrate (2.7 mg mL−1; Thermo Fisher) in
1-octanol (Sigma-Aldrich) were applied to several spots of an LSTL slide. Five
microliter per spot of deionized water was applied to several spots on a HSTL slide
corresponding to the spots on the LSTL slide. Both slides were sandwiched for
10 min and then separated. One microliter of both the organic and aqueous phase
of each spot were diluted separately in 1 mL acetonitrile for characterization by a
Lambda 35 UV-Vis spectrometer (PerkinElmer). One microliter of both the
organic and aqueous phase of each spot were diluted separately in 50 µL acetoni-
trile for characterization by an Agilent 1100 LC/MS (Agilent Technologies).
Preparation and characterization of liposomes/lipoplexes. On-chip prepara-
tion of liposomes/lipoplexes was performed under sterile conditions using a
standard sterile clean bench: A sterile ﬁltered (0.45 µm sterile syringe ﬁlter)
transfection solution of 0.04% w/v gelatin (Sigma-Aldrich), 3.4% w/v sucrose
(Sigma-Aldrich), 0.002% w/v human ﬁbronectin (Sigma-Aldrich) and—in case of
formation of lipoplexes—plasmid DNA (75 ng µL−1 of pCS2+GFP) in aqueous
sodium acetate buffer (50 mM, pH 5, Merck) was prepared for post-synthetic
processing of the lipidoid library to form a liposome or lipoplex library. In all,
4.5 µL of prepared transfection mixture was printed onto each spot of a HSTL slide
C by a non-contact liquid dispenser (I-DOT; Dispendix), followed by sandwiching
the slide C with dried LSTL lipidoid library slide A for 1.5 h at 50 °C using an
alignment frame to form liposomes or lipoplexes. For characterization via
dynamic light scattering (DLS) and zeta potential, 2 µL of processed liposome/
lipoplex solution of a single spot were pipetted into 1 mL sodium acetate buffer
(50 mM, pH 5) for analysis by Malvern Zetasizer Nano ZS (Malvern). Data were
collected at 25 °C with an acquisition time of 15 s and the diameter size was
averaged over 3 × 15 runs.
For positive control we used ScreenFect dilution buffer containing 0.04% w/v
gelatin, 3.4% w/v sucrose and 0.002% w/v human ﬁbronectin. In a PCR tube we
mixed 12.6 µL of ScreenFect A (Screenfect) into 23.7 µL ScreenFect dilution buffer
and incubated for 5 min at room temperature. In a separate PCR tube, we mixed
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1.67 µL plasmid DNA (2.05 µg µL−1 of pCS2+GFP) into 6.93 µL ScreenFect
dilution buffer. The ScreenFect A solution was mixed into the plasmid DNA and
incubated for 20 min at room temperature. Thus, led into to formation of
lipoplexes with the same calculated pDNA to lipid ratio of our synthesized samples
of 0.273 µg µL−1. We applied 4.5 µL of prepared ScreenFect solution to unused
spots of the library array after processing of the lipidoid library to liposome/
lipoplex library. For negative control we applied 4.5 µL buffer solution to unused
spots after liposome/lipoplex formation. Furthermore, we also screened spots
without any compounds for negative control. All spots were dried under
atmosphere pressure and sterile conditions for 2 h before continuing with cell
seeding for reverse transfection.
Reverse transfection and cell culture. On-chip reverse transfection was per-
formed under sterile conditions using a standard sterile clean bench: For our
transfection experiments, we used human embryonic kidney (293T (ATCC®
CRL3216™)) cells provided by the Institute of Toxicology and Genetics (ITG) at
Karlsruhe Institute of Technology (KIT). Cells were cultured in Dulbecco’s Mod-
iﬁed Eagle Medium (Life Technologies) supplemented with 10% v/v fetal bovine
serum (PAA Laboratories) and 1% v/v penicillin-streptomycin (Life Technologies)
in a humid incubator at 37 °C with 5% CO2, and were passaged every 2–3 days.
Cells were washed with phosphate buffered saline (Life Technologies), detached
with 0.25% trypsin/EDTA solution (Life Technologies) and counted by Countess
Automated Cell Counter (Life Technologies). Cells were stained by mixing 10 µL
cell suspension into 10 µL trypan blue stain solution (Life Technologies). Ten
microliter of this mixture were applied into cell counting chamber (Life Tech-
nologies) for counting the cells.
Culture medium for on-chip transfection experiments contained 15% v/v fetal
bovine serum and 1% v/v PenStrep. After detachment of the cells from culture
plate, the cells were centrifuged at 1200×g for 3 min at room temperature to form a
cell bead. The old medium was removed and then the cells resuspended again with
freshly prepared medium. Cell suspension containing 60,000 cells mL−1 were
prepared and 5 µL of that suspension was printed onto each spot of the lipoplex
slide C using a non-contact liquid dispenser (I-DOT; Dispendix). We placed the
seeded cell slide in a Petri dish whose lid we had prepared with a 7 mL phosphate
buffer saline soaked sterile tissue (Clean and Clever)—to prevent media
evaporation of the droplets. The whole Petri dish was then placed in a humid
incubator for 48 h at 37 °C with 5% CO2. After culturing the cells for reverse
transfection, cells were stained by dispensing 1 µL staining solution onto each spot
of the array containing Hoechst 33342 in dilution of 1:900 (10 mgmL−1,
Invitrogen) to stain the nucleus and propidium iodide in a dilution of 1:1350
(1.00 mgmL−1, (Invitrogen)) to stain dead cells.
Image acquisition and analysis. Fluorescence images were obtained using the
microscope Keyence BZ9000 (Keyence). The exposure times were set and kept the
same for all experiments and repetitions. Images were taken using a ×10 objective.
Objective: Nikon ×10 Plan Apo NA 0.45/4.00 mm
Resolution: 8-bit
Format: 1360 × 1024 px
Light source: mercury vapour lamp
Cells were counted by adjusting the threshold of the 8-bit images and then using
the Analyze Particles function in ImageJ. The ration of transfected cells in GFP
channel and total number of cells in Hoechst channel revealed transfection
efﬁciency of a sample. All date sets were depicted as mean ± standard deviation. At
least three replicates per slide and at least three slides were tested for each
transfection sample.
Reporting summary. Further information on research design is available in
the Nature Research Reporting Summary linked to this article.
Data availability
The data that support the ﬁndings of this study are available from the corresponding
author upon reasonable request. The source data underlying Figs. 3c, 4b, and 5b and
Supplementary Figs. 1, 5a–c, 6a–d, 7, 8, 9, 10a–e, 11a–b, and 12 and Supplementary
Tables 1, 2 and 3 are provided as a Source Data ﬁle.
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